Comments on "Treating Charles Bonnet syndrome: Understanding inconsistency" [2]

Journal of Clinical Psychopharmacology

Volumn 21, Issue 4, 2001, Pages 455-456

  Terao, T ^a   Collinson, S ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; NEUROTRANSMITTER; RISPERIDONE; SEROTONIN 2 RECEPTOR; VALPROIC ACID;

CHARLES BONNET SYNDROME; CLINICAL FEATURE; DRUG EFFECT; HALLUCINOSIS; HUMAN; HYPOTHESIS; LETTER; NEUROTRANSMISSION; ORGANIC BRAIN SYNDROME; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SYMPTOM; VISUAL ACUITY; VISUAL HALLUCINATION;

ANTIPSYCHOTIC AGENTS; HALLUCINATIONS; HUMANS; NEUROTRANSMITTER AGENTS; SEROTONIN; SYNDROME;

EID: 0034922148     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200108000-00016     Document Type: Letter

References (11)

1. Treating Charles Bonnet syndrome: Understanding inconsistency
2. The Charles Bonnet syndrome in perspective
3. Isolated visual hallucinations and the Charles Bonnet syndrome: A review of the literature and presentation of six cases
4. Social and psychological characteristics of elderly visually handicapped patients with the Charles Bonnet syndrome
5. Charles Bonnet syndrome with auditory hallucinations: A diagnostic dilemma
6. Charles Bonnet syndrome and dementia
7. Complex visual hallucinations: Clinical and neurobiological insights
8. Successful treatment of Charles Bonnet syndrome type visual hallucinosis with low-dose risperidone
9. Charles Bonnet syndrome
10. Effect of carbamazepine and clonazepam combination on Charles Bonnet syndrome: A case report
11. Treatment of Charles Bonnet syndrome with valproate